Viral Hepatitis in Reproductive Health. March 15th, 2006

Similar documents
EVALUATION OF THE SCHOOL-BASED HEPATITIS B VACCINATION PROGRAMME IN CATALONIA (SPAIN)

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature

NHS public health functions agreement Service specification No.1 Neonatal hepatitis B immunisation programme

The Aboriginal Maternal and Infant Health Service: a decade of achievement in the health of women and babies in NSW

Hepatitis B Positive: Care of Mother Policy

Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-coldchain delivery strategy. Istanbul, Turkey March 15-17, 2006

MOBILE BANKING IN TUBERCULOSIS DETECTION - BANGLADESH. C. Kliesch

HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board

Chapter 5 Serology Testing

ZIMBABWE: Humanitarian & Development Indicators - Trends (As of 20 June 2012)

Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.

Hepatitis B and Hepatitis B Vaccine

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Hepatitis B Positive: Care of Mother Policy

EAST LONDON INTEGRATED CARE

MA PERINATAL HEPATITIS B PREVENTION PROGRAM

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting

namibia Reproductive Health at a May 2011 Namibia: MDG 5 Status Country Context

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

Countdown to 2015: tracking progress, fostering accountability

Improving Care Quality to Respond to the Zika Outbreak in Latin America. Jorge Hermida, MD Regional Director for the Latin America Region

How Family Planning Saves the Lives of Mothers and Children and Promotes Economic Development

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Uganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

The hexavalent DTaP/IPV/Hib/HepB combination vaccine

Seroprotection after Hepatitis B Vaccination among Newborn Infants: a Review

Islamic Republic of Afghanistan Ministry of Public Health

Cote D'Ivoire. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

Crucial factors that influence cost-effectiveness of universal hepatitis B immunization in India Prakash C

Botswana. HIV Country Profile: Health expenditure, total (% of GDP) (2016) Total fertility rate (births per woman) ( )

How to affect Financial Flows for Population Activities on Primary Level in Turkey

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

Viral Hepatitis B and C in North African Countries

LAO PEOPLE'S DEMOCRATIC REPUBLIC

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

Eswatini. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

NHS public health functions agreement

Resourced civil society organisations should work hand-in-hand with the government to move to the grassroots.

in pregnancy Document Review History Version Review Date Reviewed By Approved By

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Viral Hepatitis in Reproductive Health

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Hepatitis B (Hep-B) is one of the most

ARTF RESULTS STORIES 2016

COUNTRY STATEMENT (MALAYSIA)

IHI South Africa Quarterly Report

Update: ACIP Recommendations for Hepatitis B Vaccination

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Meeting the MDGs in South East Asia: Lessons. Framework

VHPB Meeting, Israel Prof Shmuel Rishpon Head of the Advisory Committee on infectious diseases and Immunization Ministry of Health Israel

Perinatal Hepatitis B Prevention Program. Purpose

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

STRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL ( ) POLICY BRIEF

Adverse Event GACVS. Global Advisory Committee on Vaccine Safety, 910 June 2005

STATE TDAP VACCINE PROGRAM

The Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

DEVELOPING INFRASTRUCTURE FOR SAFE AND SECURE CHILDBIRTH

Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific

PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders

HEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011

TERMS OF REFERENCE CAM Association Strengthening Consultants Strengthening Midwifery Services (SMS) Project, South Sudan

General information on infant feeding

Primary and secondary hepatitis prevention and control programmes The Netherlands

X-Plain Hepatitis B Reference Summary

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Status of human health in india: Emerging issues in the era of globalisation

The estimated prevalence of cases in Jordan is 0.02%. These estimates are based on several existing factors outlined below. The fact that these

HEPATITIS B ELIMINATION IN ALASKA Lisa Townshend-Bulson, RN, MSN, FNP-C Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium

CARE OF HEPATITIS B POSITIVE MOTHER

HBV-2 Group: neonates born to HBsAg+ and HBeAg+ mothers who received a 4-dose vaccination regimen (Part of

Hepatitis and pregnancy

Prevention of and Immunisation against Hepatitis B and C

Global Health. Transitions. Packet #1 Chapter #1

Progress towards achieving Millennium Development Goal 5 in South-East Asia

HIV, HBV and HCV testing policy experiences and lessons learned.

AN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS

HIV and women having children

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Fifty-fourth session Brazzaville, Republic of Congo, 30 August 3 September 2004

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

HIV AND INFANT FEEDING

Integrated Hepatitis B prevention in PMTCT program in Chamanculo maternity Maputo, Mozambique

Perinatal Hepatitis b Prevention

Partners In Health from Origins to Ebola: Lessons Learned from Haiti. Cate Oswald, MPH Senior Program Officer, Haiti Partners In Health

THANH TUNG MEDICAL STATION Annual Report 2014

Dear Delegates, It is a pleasure to welcome you to the 2015 Montessori Model United Nations Conference.

International political economy of health (part II)

Technical matters: Viral hepatitis

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

Ex Post-Evaluation Brief BURUNDI: Health Sectoral Programme II

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

Transcription:

Training in Reproductive Health Research WHO - Geneva 2006 Viral Hepatitis in Reproductive Health March 15th, 2006 Hepatitis B - Honduras Research Challenges for Northern NGOs Working in Developing Countries Francesco Aureli IMAGINE Director

Part 1 Prevalence of the Hepatitis B chronic carrier state among pregnant women in Honduras, and prevention of vertical transmission

Honduras Physical Geography Area: 112,090 sq km Terrain: Mostly mountainous, with narrow coastal plains Climate: Subtropical in lowlands and temperate in the mountains

Honduras Demographics Population: 6,823,568 Median age: 19 years (Italy: 41.4) Population growth rate: 2.24% Birth rate: 31.04 / 1000 Death rate: 6.64 / 1000 Total fertility rate: 3.97 children / fertile aged woman

Honduras Economy GDP per capita: $2,600 (only Nicaragua, Cuba and Haiti have a lower GDP in the Western Hemisphere) Population below poverty line: 53% Unemployment rate: 27.5%

Honduras Health Indicators Life expectancy at birth: 66.15 years Infant mortality rate: 42 / 1000 live births (USA: 7.1) Maternal mortality rate: 108 / 100,000 live births (USA: 9.9)

Hepatitis B in Honduras WHO classifies Honduras as a moderately endemic country (2% to 7% prevalence) It is unclear, however, how these estimates were made (local health authorities lack reliable data) Only epidemiological survey to date suggests ~ 3% of pregnant women are chronic carriers

Eradication Efforts Hepatitis B vaccine (Engerix) has been made part of the Expanded Program for Immunizations (EPI) in Honduras First dose given at 6 to 8 weeks of age

Vertical Transmission Transmission from mother to child (almost always at the time of birth) Risk of the child becoming chronic carrier depends on mother s serology: If mother is HBsAg+ only: 10-30% If mother is also HBeAg+: 70-90% To protect the child, the first dose of the vaccine must be given as close as possible to the time of birth

Aims To determine the prevalence of chronic hepatitis b infection, as indicated by the presence of HBsAg, among pregnant women To assess the risk level of vertical transmission, given the HBeAg status of women found to be HBsAg carriers To assess the efficacy in Honduras of Engerix, a recombinant hepatitis b vaccine, to prevent vertical transmission

What are we going to accomplish? Reliable data, to help formulate health policy Prevention of vertical transmission Referral of HBsAg+ mothers to the Ministry of Health for epidemiological follow-up

Our local partner The Instituto Hondureño del Seguro Social - Autonomous institution, providing pensions and healthcare - Covers close to a million hondurans (400,000+ workers and 500,000+ dependents) - Has hospitals in the two largest urban centers (Tegucigalpa and San Pedro Sula)

Data collection and management 4000 pregnant women followed at the Hospital de Especialidades and the Hospital Regional del Norte Basic demographic information, blood for HBsAg and HBeAg determinations Establishment of a serum bank Design and development of a research database

Main intervention Preventing vertical transmission First dose of vaccine to be administered within 24 hours of birth Long-term follow up of vaccinated babies

Our contribution Analytical Study design Project Implementation Database design Statistical and cost-effectiveness analysis

Our contribution Material Equipment: Freezer (serum bank) Computers Cost of serological testing: HBsAg; HBeAg Vaccine Personnel: Research assistant, full time Research assistant, part time Data entry clerk, part time Analytical software

Part 2 Challenges for Northern NGOs Working in Developing Countries

The Challenges Assessment of the real needs Identification and consultation of local partners: -Decide objectives together -Build up mutual trust -Share information -Share responsibilities (asses capacities of partners) -Create transparency Analysis of the cultural, economical, ecological and social implication of the initiative Adoption of an holistic approach Coordination with local authorities and other actors working in the same territory/sector

The Challenges Attention to collusion and corruption Involvement and agreement of local communities (do not create high expectations) Clarity about project goals (while the implementation has to remain flexible to respond to undefined variables and changing circumstances) Clarity about organisational structure and schedule Attention to sustainability Estimation of the costs Development of local expertise Monitoring and evaluation

We choose to go to the moon. We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard, because that goal will serve to organize and measure the best of our energies and skills, because that challenge is one that we are willing to accept, one we are unwilling to postpone, and one which we intend to win John Fitzgerald Kennedy September 12, 1962

Engage!